Adaptive Designs in Clinical Trials 2017 Highlights Key Themes in the Industry
SMi launches an exclusive conference on Clinical Trials, taking place on 3rd and 4th April 2017 in London.
London, United Kingdom, March 10, 2017 --(PR.com)-- Bringing together industry leaders who will drive innovation and success in medical product development, SMi’s 9th annual Adaptive Designs in Clinical Trials is set to open its doors in a few weeks’ time.
Some key significant themes attendees will explore at the two-day event:
• New Approaches in Adaptive Designs
Includes case studies and success stories by big pharma companies and sessions on multi-arm randomisation approaches and a historical perspective on how adaptive design rose
Presentations by: Novartis, Boehringer-Ingelheim, Gunenthal, Medicines Assessment
• Strengthening Clinical Development Strategies
Includes sessions on Bayesian adaptive designs, device development, integration into neuroscience drug development and clinical development from patent to market
Presentations by: Livanova, Blueberry Therapeutics, The Cure Parkinson’s Trust, University of Bath
• Optimising Drug Development in Key Therapy Areas
Includes sessions on building adaptive design capabilities in early development and how preclinical, translational and big data can contribute to better designs
Presentations by: AstraZeneca, Ispen, Berry Consulting, Pfizer
• Industry-led Approaches to Clinical Trial Success
Includes sessions on enrichment designs in oncology, industry experience on adaptive dose finding designs and biomarker-driven drug development
Presentations by: Sanofi, Pfizer, Amgen
• How to Meet Regulatory Requirements for Adaptive Designs
Panel Discussion discussing strategies for upfront statistical and operational planning to meet regulatory requirements.
Panelists: Ispen, EMA, AstraZeneca, Novartis
For more details about the full conference agenda and registration information, visit www.adaptivedesigns.co.uk/prcom
Adaptive Designs In Clinical Trials
3-4 April 2017
Holiday Inn Kensington Forum, London, UK
www.adaptivedesigns.co.uk/prcom
Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Fateja Begum at fbegum@smi-online.co.uk. For media queries please contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Some key significant themes attendees will explore at the two-day event:
• New Approaches in Adaptive Designs
Includes case studies and success stories by big pharma companies and sessions on multi-arm randomisation approaches and a historical perspective on how adaptive design rose
Presentations by: Novartis, Boehringer-Ingelheim, Gunenthal, Medicines Assessment
• Strengthening Clinical Development Strategies
Includes sessions on Bayesian adaptive designs, device development, integration into neuroscience drug development and clinical development from patent to market
Presentations by: Livanova, Blueberry Therapeutics, The Cure Parkinson’s Trust, University of Bath
• Optimising Drug Development in Key Therapy Areas
Includes sessions on building adaptive design capabilities in early development and how preclinical, translational and big data can contribute to better designs
Presentations by: AstraZeneca, Ispen, Berry Consulting, Pfizer
• Industry-led Approaches to Clinical Trial Success
Includes sessions on enrichment designs in oncology, industry experience on adaptive dose finding designs and biomarker-driven drug development
Presentations by: Sanofi, Pfizer, Amgen
• How to Meet Regulatory Requirements for Adaptive Designs
Panel Discussion discussing strategies for upfront statistical and operational planning to meet regulatory requirements.
Panelists: Ispen, EMA, AstraZeneca, Novartis
For more details about the full conference agenda and registration information, visit www.adaptivedesigns.co.uk/prcom
Adaptive Designs In Clinical Trials
3-4 April 2017
Holiday Inn Kensington Forum, London, UK
www.adaptivedesigns.co.uk/prcom
Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Fateja Begum at fbegum@smi-online.co.uk. For media queries please contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Honey de Gracia
+44 (0) 207 827 6102
www.adaptivedesigns.co.uk/prcom
Honey de Gracia
+44 (0) 207 827 6102
www.adaptivedesigns.co.uk/prcom
Contact
Categories